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Summary 
 
Vascular integrity is fundamental to the formation of mature blood vessels and depends on a functional, 
quiescent endothelial monolayer. However, how endothelial cells enter and maintain quiescence in the presence 
of angiogenic factors is still poorly understood. Here we identify the fibroblast growth factor (FGF) antagonist 
Sprouty2 (Spry2) as a key player in mediating endothelial quiescence and barrier integrity in mouse aortic 
endothelial cells (MAECs): Spry2 knockout MAECs show spindle-like shapes and are incapable of forming a 
functional, impermeable endothelial monolayer in the presence of FGF2. Whereas dense wild type cells exhibit 
contact inhibition and stop to proliferate, Spry2 knockout MAECs remain responsive to FGF2 and continue to 
proliferate even at high cell densities. Importantly, the anti-proliferative effect of Spry2 is absent in sparsely 
plated cells. This cell density-dependent Spry2 function correlates with highly increased Spry2 expression in 
confluent wild type MAECs, while express Spry2. Spry2 protein expression is barely detectable in single cells 
but steadily increases in cells growing to high cell densities, with hypoxia being one contributing factor. At 
confluence, Spry2 expression correlates with intact cell-cell contacts, whereas disruption of cell-cell contacts by 
EGTA, TNF and thrombin decreases Spry2 protein expression. In confluent cells, high Spry2 levels correlate 
with decreased extracellular signal-regulated kinase 1/2 (Erk1/2) phosphorylation. In contrast, dense Spry2 
knockout MAECs exhibit enhanced signaling by Erk1/2. Moreover, inhibiting Erk1/2 activity in Spry2 knockout 
cells restores wild type cobblestone monolayer morphology. This study thus reveals a novel Spry2 function, 
which mediates endothelial contact inhibition and barrier integrity. 
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Introduction 
 
During angiogenesis a concerted action of hypoxia and growth factors including vascular endothelial growth 
factor (VEGF) and fibroblast growth factors (FGFs) induces the formation of endothelial tip cells and stalk cells, 
and promotes vascular cell proliferation, cell migration, and lumen formation [1-4]. Ultimately, these cells 
mature and stabilize into new, functional blood vessels that are able to control permeability and to supply the 
newly vascularized areas with oxygen and nutrients. In this physiological state, endothelial cells form a tight 
monolayer, resist apoptosis and remain quiescent (defined as reversible cell growth/proliferation arrest) even in 
the presence of angiogenic factors [5,6].  
Endothelial cells in culture can display either an “activated” or a “quiescent” phenotype. The behavior of 
growing angiogenic (activated) cells is recapitulated by endothelial cells growing in sparse culture in vitro 
(thinly scattered cells), whereas a tight monolayer of cultured endothelial cells that is arranged in a cobblestone 
morphology is quiescent [5]. It has been suggested that several surface molecules associated with adherens and 
tight junctions mediate cell-contact inhibition (cells undergo growth arrest when they come into contact with 
each other) and vascular integrity through regulation of intracellular signaling cascades and transcription [7]. 
Endothelial cells mediate contact inhibition of growth in part by exiting cell cycle in response to the inhibition of 
extracellular signal-regulated kinase 1/2 (Erk1/2) activity, a major mitogen-activated kinase (MAPK) 
downstream of FGF and other angiogenic growth factors [8]. 
An important class of negative regulators of receptor tyrosine kinase (RTK) dependent MAPK activation is the 
Sprouty (Spry) family of proteins. In Drosophila, Sprouty (dSpry) modulates trachea branching [9] by inhibiting 
the RTK/Ras/Erk signaling downstream of different growth factors [10]. Sprouty2 (Spry2), one of four 
mammalian homologs, exhibits the highest sequence conservation across species [11] and plays a comparable 
role to dSpry in regulating the embryonic lung branching morphogenesis in mammals [12]. Furthermore, Spry2 
modulates MAPK-signaling in embryogenesis [13,14], organ development [15], and angiogenesis in vivo and in 
vitro [16,17]. Spry2 is therefore a potential candidate to mediate cell-contact inhibition in endothelial cells. 
Here, we have assessed the potential role of Spry2 in cell-contact inhibition and the formation and maintenance 
of the endothelial monolayer. We compared the ability of primary Spry2 expressing (Spry2
fl/fl
) and Spry2 
knockout (Spry2
-/-
) mouse aortic endothelial cells (MAECs) to form a functional endothelial monolayer. 
Furthermore, we analyzed Spry2 expression and Erk1/2 activity in MAECs plated at defined cell densities. We 
were particularly interested of how endothelial cells process signals arising from increasing cell density to allow 
a switch from a proliferative, migratory phenotype to a quiescent, impermeable monolayer. 
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Materials and methods 
 
Cell culture and treatments  
 
Mouse aortic endothelial cells (MAECs) were isolated from aortae of C57BL/6 wild type male mice (MAECs ♂) 
or Sprouty2 floxed female mice (Spry2 floxed MAECs ♀) as described in a previous study (Humar et al., 2002). 
Cells were used for experiments up to passage 10. For all experiments in this study, cell culture dishes were 
coated with 0.1% gelatin (Carl Roth GmbH, Karlsruhe, Germany) for 20 minutes at 37°C. Cells were maintained 
in growth media (GM) [DMEM (Biochrom, Berlin, BW, Germany) complemented with 1% or 10% FCS, 1% 
sodium pyruvate, 1% non-essential amino acids, and 1% penicillin-streptomycin (Invitrogen, Carlsbad, CA, 
USA)] in a humidified 5% CO2-air atmosphere at 37°C. Serumfree media (GM without FCS) was used for 
starvation. Cell numbers were assessed with a NucleoCounter® NC-100™ (Chemometec, Allerød, Denmark). 
MAECs were treated with one or more of the following growth factors and inhibitors: FGF2 25 ng/ml (R&D 
Systems, Minneapolis, MN, USA); MG132 5 M and EGTA 2.5 mM (Merck, Billerica, MA, USA); Bapta-AM 
10 M (Invitrogen); TNF 50 ng/ml (R&D Systems); thrombin 10 u/ml (Sigma-Aldrich, St. Louis, MO, USA), 
and U0126 5 M (Promega, Madison, WI, USA). To create a hypoxic environment, cells were placed in a 
hypoxia incubator (Hera Cell 150) (Thermo Fisher Scientific, Waltham, MA, USA) with 1% oxygen for 24 
hours. Micrograph pictures of cells were taken with a digital camera (F-viewXS) (Olympus, Hamburg, 
Germany) and an inverted microscope (1X71) (Olympus). GFP expression was monitored by using a U-
LH100HG light source with a U-MWB2 filter (Olympus). 
 
Generation of Spry2 knockout cells 
 
We seeded 800,000 Spry2 floxed MAECs (♀) on a 10-cm culture dish. The next day, the media was removed 
and a virus (100 MOI) that contained either Ade-CRE-GFP or Ade-CMV-GFP (Vector Biolabs, Philadelphia, 
PA, USA) was added in 3 ml of growth media to the cells. After 6 hours, the media was removed, replaced by 10 
ml of normal growth media, and then incubated at 37°C. Endothelial cells expressed GFP the following day. 
Down-regulation of Spry2 was assessed by using qRT-PCR and Western blot. Steps that involved handling 
viruses or virus-transfected cells were undertaken in a level-2 biosafety hood (VSB 90) (Skan, Allschwil, Basel, 
Switzerland) in a certified cell culture laboratory.  
 
mRNA extraction and quantitative real-time PCR 
 
To isolate RNA from cells, cells were first harvested by scraping with a cell scraper (BD) and the RNA then 
isolated by using RNeasy kit (Qiagen, Hilden, NRW, Germany) according to directions in the manufacturer’s 
manual. The RNA was then reverse transcribed to cDNA by using the Taqman Kit (Applied Biosystems, Foster 
City, CA, USA). The following primers were used for qRT-PCR: Spry2-fwd 
(ATAATCCGAGTGCAGCCTAAATC), Spry2-rev (CGCAGTCCTCACACCTGTAG), GAPDH-fwd 
(TGTGTCCGTCGTGGATCTGA), and GAPDH-rev (CCTGCTTCACCACCTTCTTGA). The cDNA samples 
and the forward and reverse primers for the endogenous control gene (GAPDH) and the target gene (Spry2), 
together with SYBR green PCR master mix (Applied Biosystems) were loaded on a 96-well PCR reaction plate. 
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Data was collected and normalized to GAPDH by running the relative quantitation program with the 7500 real 
time PCR system (Applied Biosystems).  
 
Immunoblotting 
 
To extract protein from the cells, cells were washed twice with ice-cold PBS and then harvested by scraping with 
a cell scraper (BD, Franklin Lakes, NJ, USA) into1 ml of ice-cold PBS. The cell suspension was collected and 
then centrifuged for 5 minutes at 14,000 rpm at 4°C. The pellet was re-suspended in RIPA buffer that contained 
a complete mini protease inhibitor (Roche, Basel, Switzerland) and a phosphatase inhibitor cocktail 2 (Sigma-
Aldrich) and then was lysed by using liquid nitrogen in four freeze-and-thaw cycles. The sample was centrifuged 
for 15 minutes at 14,000 rpm at 4°C. The resulting supernatant was collected and the protein concentration 
measured by using a BCA protein assay kit (Thermo Fisher Scientific). Equal amounts of protein were separated 
by SDS-PAGE and then transferred to a nitrocellulose membrane (BA85) (Whatman, Maidstone, Kent, UK) by 
using a semidry blotting procedure. Membranes were blocked for 1 hour at room temperature (RT) in TBS that 
contained 5% skim milk powder (Sigma-Aldrich), washed once with TBS that contained 0.1% tween (TBST) 
and then incubated overnight at 4°C with one of the following primary antibodies: rabbit anti Sprouty2 (H-120) 
1:4,000 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit anti Sprouty2 (ab50317) 1:1,000 (Abcam, 
Cambridge, Cambs, UK); rabbit anti pospho-Erk1/2 (9102) 1:1,000, and rabbit anti total-Erk1/2 (9102) 1:1,000 
(Cell Signaling, Danvers, MA, USA); rabbit anti Hif-1 (NB100-479) 1:1,000 (Novus Biologicals, Littleton, 
CO, USA); and mouse anti -Actin 1:10,000 (A-5441) (Sigma-Aldrich). 
The next day, the membrane was washed three times in TBST and incubated with a secondary antibody—goat 
anti rabbit antibody HRP (7074) 1:5,000 – 1:20,000 (Cell Signaling) or anti mouse HRP (7076) (1:80,000) (Cell 
Signaling)—for 1 hour at RT. After another wash step, a chemiluminescent substrate that is used for the 
detection of HRP (Thermo Fisher Scientific) was applied to the membrane for 1 minute. The signal was detected 
with CL-XPosure film (Thermo Fisher Scientific), and the resulting bands were quantified by using ImageJ 
(Wayne Rasband, NIH, MD, USA).  
 
Proliferation Assay  
 
Spry2 KO and Spry2 wilt type MAECs (♀) were seeded at the indicated densities in 8 replicates and grown in 
100 l of growth media with 1% FCS in a 96-well plate both with and without 25 ng/ml of FGF2. After 48 
hours, 10 l of alamarBlue® solution (Invitrogen) was added for 3 hours. Fluorescence was measured (Ex 560; 
Em 590) by using a Spectramax M2 reader (Molecular Devices, Sunnyvale, CA, USA).  
 
Permeability assay 
 
The permeability assay was performed according to directions in the manufacturer’s manual (Millipore, 
Billerica, MA, USA). 200,000 Spry2 KO and Spry2 wild type MAECs (♀) were suspended in 200 l of 
complete growth medium supplemented with 1% FCS and both with and without 25 ng/ml of FGF2. The cells 
were then seeded in triplicate on cell culture inserts (3-m pore size) (Millipore) and placed in 24-well culture 
plates (BD) that contained 600 l of FGF2-free medium per well. After 48 hours, the inserts were moved to a 
 6 
new 24-well plate and 70 kDa FITC-dextran was added for 10 minutes. Fluorescence at Ex 585 nm and Em 520 
nm of the lower well compartments was analyzed by using a Spectramax M2 reader. 
 
Oxygen sensing 
 
Changes in the oxygen saturation of cell cultures were measured in real time by using an SDR SensorDish reader 
(Presens, Regensburg, BY, Germany). MAECs (♂) were plated on an Oxodish 24-well plate (OD24) with 
integrated oxygen sensors (Presens). Oxygen saturation of the media was measured every 30 minutes and data 
was collected and analyzed by using SDR_v38 software (Presens) on a personal computer.  
 
Electric cell-substrate impedance sensing (ECIS) 
 
Electrical resistance measurements were performed using an ECIS ZӨ apparatus (Applied Biopyhysics, Troy, 
NY, USA) in 8-well (0.8 cm
2
/well) arrays with 40 (8W10E+) gold electrodes, each with a diameter of 250 m 
(Applied Biopyhysics). Each experiment was carried out in duplicate. Before seeding the cells, each well was 
pre-incubated with serum-free DMEM overnight that was followed by a 20 minute coating with 0.1% gelatin 
(Carl Roth GmbH) and 0.9% sodium chloride in PBS followed by three wash steps with growth media. The 
arrays in the measurement station were then placed in an incubator (37°C, 5% CO2) to allow real time 
monitoring. Total resistance was measured at a frequency of 4 kHz. Initial baseline values were normalized to 1.  
 
Statistical analysis 
 
All statistical tests were performed by using GraphPad Prism 5.04 for Windows® (GraphPad software, San 
Diego, CA, USA). We use unpaired t-test to evaluate differences between two groups. If there were more than 
two groups, we used one-way ANOVA, followed by a Newman-Keuls post-test. P<0.05 was considered 
significant. 
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Results 
 
Lack of Spry2 expression results in loss of contact inhibition and endothelial monolayer integrity  
 
We generated Spry2 knockout MAECs (mouse aortic endothelial cells) to explore whether Spry2 regulates the 
formation of the endothelial monolayer and thereby mediates cell-contact inhibition. Adenoviral transfection of 
floxed-Spry2 MAECs with a Cre recombinase encoding expression vector (Ade-CRE-GFP), but not with a 
control vector (Ade-CMV-GFP), efficiently down-regulated Spry2 mRNA and protein levels (Fig. 1A-D).  
Spry2
-/-
 (knockout) and Spry2
fl/fl 
(wild type) MAECs were then seeded at confluence in the presence or absence 
of FGF2. We observed that Spry2
-/-
 MAECs grown for 48 hours in the presence of FGF2, were incapable of 
forming a mature monolayer and displayed an elongated, angiogenic phenotype with longitudinal gaps between 
the cells and little cell-cell contacts (Fig. 2A2). In contrast to the latter results, control Spry2
fl/fl
 MAECs formed a 
regular cobblestone-type cell monolayer with only a few elongated cells (Fig. 2A1). FGF2 was required to 
disturb layer formation in Spry2
-/-
 MAECs, because without FGF2 stimulation, Spry2
-/-
 and Spry2
fl/fl 
cells both 
formed a regular mature monolayer (Fig. 2A1,A2).  
To further characterize the perturbed endothelial monolayer formation by Spry2
-/-
 cells, we analyzed monolayer 
permeability. Indeed, the monolayer formed by Spry2
-/-
 cells exhibited significantly increased permeability to a 
70 kDa FITC-dextran in the presence of FGF2, while no difference was observed in cells without FGF2 (Fig. 
2B). Spry2
-/-
 MAECs appear to fail in establishing cell contact inhibition. We therefore asked, whether Spry2
-/-
 
cells show increased cell proliferation. We then plated the cells at different densities and let them grow for 48 h 
in the presence or absence of FGF2 before evaluating the cell cumbers. No difference was observed between 
Spry2
-/-
 and Spry2
fl/fl
 when cells were plated at initially sparse conditions (3,000 cells/cm
2
) (Fig. C1). However, 
when the cells were plated with a higher initial density (6,000 and 12,000 cells/cm
2
), the cell numbers increased 
significantly in Spry2
-/-
 MAECs as compared to Spry2
fl/fl 
MAECs after 48 hours of FGF2 stimulation (Fig. C2, 
C3). No difference was observed between Spry2
-/-
 and Spry2
fl/fl
 when cells were grown without FGF2. These 
findings indicate that Spry2 is indispensable for endothelial cell monolayer formation and the maintenance of 
barrier integrity in the presence of FGF2. Apparently, the function of Spry2 thereby depends on an increased cell 
density. 
 
High cell density induces Spry2 expression  
 
Next we asked, whether the Spry2 function at high cell densities correlated with increased Spry2 expression at 
high cell densities. We therefore compared Spry2 protein expression of cells, which were seeded at different 
densities (Fig. 3A). Sparsely plated cells (1,500 – 6,000 cells/cm2) expressed Spry2 protein at very low levels. 
Subconfluently plated cells (12,000 – 25,000 cells/cm2) increased Spry2 protein markedly. Plating 50,000 
cells/cm
2
 led to the formation of a confluent monolayer and a strong induction Spry2 protein (Fig. 3B). We then 
analyzed the Spry2 mRNA expression of sparse (3,000 cells/cm
2
) and confluent cells (50,000 cells/cm
2
) and 
compared it to the corresponding protein expression. Whereas the Spry2 protein levels increased 70 fold in 
confluent compared to sparse cells, the mRNA levels increased only moderately (two fold), suggesting that 
density dependent Spry2 expression is regulated predominantly at a post transcriptional level. 
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To better understand the fashion of cell density-induced Spry2 expression, we analyzed Spry2 protein expression 
during formation of the endothelial monolayer. MAECs were plated sparsely and grown to high cell density and 
confluence over a time period of 24 to 96 hours (Fig. 4A). Spry2 expression increased markedly after 48 hours, 
and reached its maximum level between 72 and 96 hours after seeding (Fig. 4B). Thus, Spry2 protein expression 
increased not only when cells were plated at high cell density, but also when cells grow from an initial sparse 
culture to a confluent culture. 
 
Hypoxia increases Spry2 expression during formation of the endothelial monolayer  
 
Conventional monolayer cultures are often hypoxic when incubated in an air/5% CO2 atmosphere [18]. Thus, 
hypoxia that results from increased oxygen-consumption during endothelial monolayer formation may correlate 
with high cell density and may upregulate Spry2 expression. To investigate this hypothesis, we analyzed the 
expression of the hypoxia marker Hif-1 over a time period of 24 to 96 hours. Hif-1 levels increased at 48 
hours, dropped at 72 hours, and were undetectable after 96 hours of cell seeding (Fig. 4A). We then further 
substantiated these findings by measuring oxygen levels of sparsely seeded cells directly and in real time over a 
period of 0-96 hours: Oxygen saturation decreased slightly after 24 hours (80% O2 saturation) and declined to a 
minimum between 48 and 72 hours after cell seeding (70% O2 saturation) compared to a control with no cells 
present (85% O2 saturation throughout the experiment) (Fig. 4B). These results demonstrate that increased Spry2 
expression after 48 hours of endothelial cells growing to confluence is accompanied by hypoxia and elevated 
Hif-1 expression. 
To investigate whether hypoxia indeed induces Spry2 protein expression, we reduced oxygen consumption by 
starving the cells to reduce metabolism [18]. Indeed, Spry2 protein levels decreased but were still detectable in 
starved cells (Fig. 4C). In addition, Hif-1 protein levels dropped and were undetectable after changing growth 
media to serum-free conditions (Fig. 4C). In parallel experiments replacement of the growth media by serum-
free media after 24 hours reduced the oxygen consumption of the endothelial cell cultures and restored basal 
oxygen levels after 48 hours. However, in the presence of serum, oxygen levels decreased further and reached a 
minimum level (65% O2 saturation) after 48 hours of cell seeding (Fig. 4D).  
To assess whether endothelial cells cultured in serum-free medium did not lose the potential to induce Spry2 
expression under hypoxia, cells were seeded at sparse or confluent density, and serum-free endothelial cells were 
subjected to hypoxic (1% O2) and normoxic conditions in a hypoxia incubator. After 24 hours, Spry2 increased 
in cells under hypoxic conditions; this correlated with increased Hif-1 protein levels (Fig. 4E). Hypoxia, 
however, did not affect Spry2 mRNA levels (Fig. 4F). Thus, it is likely that hypoxia regulates Spry2 expression 
independent of Hif-1on a post-transcriptional level.  
 
Disruption of calcium dependent cell-cell contacts decreases Spry2 protein in confluent cells  
 
Although transient hypoxia induced Spry2 expression in the early phase of endothelial cell monolayer formation, 
it appeared that hypoxia was not necessary to maintain high Spry2 levels when the cells reached confluence 
(Figs. 3B). Therefore, we hypothesized that in confluent cells Spry2 might be stabilized at an elevated level 
through a hypoxia-independent mechanism, including cell-cell contact. 
 9 
To examine whether cell-cell contact regulates Spry2, we used ethylene glycol tetraacetic acid (EGTA) to 
chelate extracellular calcium and to disrupt calcium-dependent cell-cell contacts [19]. The addition of EGTA to 
confluent MAECs resulted in the formation of gaps between cells after 30 minutes and in a complete detachment 
from each other after 3 hours (Fig. 5A). Replacement of EGTA with new media restored the monolayer after 24 
hours of incubation. In parallel experiments, treatment with EGTA completely eliminated Spry2 expression after 
0.5 and 3 hours of EGTA treatment (Fig. 5B). The restoration of the monolayer by new media also restored 
Spry2 protein to the levels seen prior to EGTA treatment. In addition, we measured the electrical resistance of 
the confluent endothelial monolayer during EGTA treatment by electrical cell impedance sensing (ECIS). The 
electrical resistance dropped markedly after the addition of EGTA and then returned to basal levels (resistance 
prior the addition of EGTA) within 48 hours after the addition of new media. This result demonstrated that the 
effect of treatment with EGTA was reversible and did not damage endothelial cell viability (Fig. 5C). Of note, 
chelation of intracellular calcium with Bapta-AM did not affect Spry2 protein levels (Fig. 5D), and neither 
EGTA nor Bapta-AM affected Spry2 mRNA levels (Fig. 5E).  
Our results indicate that high Spry2 protein levels restrict endothelial permeability in confluent cells. Since 
several physiologic conditions such as inflammation display and require increased monolayer permeability, we 
asked whether Spry2 protein expression can be decreased by physiological mediators of endothelial permeability 
such as TNF[20,21] and thrombin [22]. Indeed, Spry2 protein expression decreased when confluent cells were 
treated for 3 hours with either TNF or thrombin as compared to the control cells (Fig. 5F). As control for the 
increased permeability, we measured the change in total resistance of cells after addition of either TNF or 
thrombin. As expected, the results showed a rapid disruption of the endothelial barrier properties by thrombin 
with partial recovery as compared to a rather chronic destabilization by TNF (Fig. 5G). Taken together, these 
findings demonstrate that density-dependent Spry2 protein expression depends on intact cell-cell contacts and is 
downregulated by agents that increases endothelial permeability. 
  
At high cell densities high Spry2 protein levels correlate with decreased Erk1/2 phosphorylation  
 
A well-established inhibitor of Erk1/2 activity downstream of FGF signaling [23,17] Spry2 might mediate cell-
contact inhibition in confluent cells via Erk1/2 inhibition. We therefore compared Spry2 expression with Erk1/2 
phosphorylation in sparse and confluent cells. In sparse cells, FGF2-induced Erk1/2 phosphorylation levels were 
detected along with low Spry2 protein levels (Fig. 3C). Vice versa, Spry2 was exclusively increased in confluent 
cells and correlated with decreased Erk1/2 phosphorylation. In the presence of FGF2, cell confluence 
significantly decreased FGF2-induced Erk1/2 phosphorylation when compared to sparse, FGF2-stimulated cells 
(Fig. 3C). Taken together, these results suggest that cell density is crucial to regulate Spry2 expression and by 
that its function as an inhibitor of FGF2-Erk1/2 signaling. 
 
Inhibition of Erk1/2 signaling restores wild type morphology of the monolayer 
 
Next we asked, whether Spry
-/-
 MAECs exhibited increased Erk1/2 phosphorylation. Indeed, in Spry2
-/-
 cells, 
FGF2-induced Erk1/2 phosphorylation levels increased 2.5 fold compared to those in Spry2
fl/fl 
cells, while 
Erk1/2 phosphorylation was absent without stimuli in both cell types (Fig. 2A1,A2).  
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We therefore investigated whether inhibiting the MAPK Erk1/2 pathway could reverse disturbed endothelial 
monolayer formation of Spry2
-/-
 cells. Spry2
fl/fl 
and Spry2
-/-
 MAECs were plated in the presence or absence of the 
Erk1/2 inhibitor U0126. In the absence of U0126, Spry2
-/-
 MAECs showed a highly angiogenic phenotype upon 
FGF2 stimulation. However, when cells were pre-incubated with U0126 before adding FGF2, the wild type 
cobblestone phenotype was restored (Fig. 2B). The absence of Erk1/2 phosphorylation upon U0126-treatment in 
both Spry2
fl/fl 
and Spry2
-/-
 MAECs demonstrated the efficacy of the Erk1/2 inhibitor (Fig. 2C). Notably, upon 
inhibition of Erk1/2 Spry2 expression was reduced in Spry2
fl/fl 
cells, indicating that
 
the expression of Spry2 is 
partly regulated by Erk1/2 signaling. These findings show that Spry2, as a regulator of Erk1/2 activity, is 
indispensable for endothelial cell monolayer formation and the maintenance of barrier integrity in the presence 
of FGF2. 
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Discussion 
 
Cell-contact inhibition is an important process for the regulation of vascular integrity for which proper 
understanding underlying molecular events is still lacking. This study therefore addresses the important question 
of how endothelial cells process signals arising from increasing cell density to allow a switch from a 
proliferative, migratory phenotype to a quiescent, impermeable monolayer. Here, we identify the FGF receptor 
signaling antagonist Spry2 as a key component in the establishment of endothelial quiescence and barrier 
integrity.  
Spry2 exclusively acts as an adaptor protein without any enzymatic activity [24]. Therefore cells have restricted 
possibilities to control Spry2 function: by regulating its abundance [25-27], its localization [17,28], and/or its 
post-transcriptional modifications [29-31]. Here we show, that in primary endothelial cells, Spry2 is regulated in 
a previously unknown cell-density dependent fashion and is found at high levels only in dense endothelial cell 
monolayers. Highly elevated Spry2 protein levels might inhibit endothelial proliferation and, thus, maintain 
vascular integrity and quiescence. Forced Spry2 expression in human umbilical vein endothelial cells was shown 
to inhibit growth factor-induced proliferation and sprouting [17]. We here demonstrate that sparse cultures of 
proliferating endothelial cells express low Spry2 protein levels and that upon reaching cell confluence and cell 
quiescence Spry2 protein levels increase by a mostly post-transcriptional mechanism. Notably, ablation of Spry2 
in dense cells increases cell proliferation and permeability of the endothelial monolayer. Thus restriction of 
Spry2 may allow endothelial cell proliferation and migration during angiogenesis and wound closure [32,16]. In 
accord with our findings, Zhang et al. showed that Spry2 protein decreased in the vasculature after an injury to 
the endothelial lining of the carotid artery in rats and then reappeared weeks later after the inner endothelial 
lining had re-formed [33]. We report that Spry2 protein levels increase steadily in cells that are growing toward 
confluence. Two independent and consecutive stimuli induce and stabilize Spry2 protein levels – transient 
intrinsic hypoxia and the establishment of cell-cell contacts. In the sub-confluent phase, Spry2 expression 
correlates with reduced oxygen saturation and increases Hif-1 protein levels. Furthermore, exogenously applied 
hypoxia increases Spry2 protein in both sparse (results not shown) and confluent cells in post transcriptional 
manner. A possible explanation for this finding is delivered by Anderson et al [25]. They showed that Spry2 
interacts with prolyl hydroxylases preferentially during normoxic conditions. When hydroxylated on proline 
residues, Spry2 is recognized by pVHL and its associated E3 ubiquitin ligase complex, resulting in Spry2 
degradation. Thus under hypoxic conditions, when PDHs are less active, Spry2 levels increase [25]. 
In vivo, hypoxia-induced Spry2 expression may provide a protective homeostatic function when the vasculature 
is exposed to hypoxia. Endothelium that is subjected to oxygen deprivation maintains cell viability and basic 
biosynthetic mechanisms, but it displays multiple changes in barrier function that are relevant to vascular 
homeostasis [34,35].  
The observation that Spry2 expression still remains elevated in confluent cells showing normoxic oxygen levels 
points to another essential mechanism for stabilizing Spry2 in confluent cultures: intact cell-cell contacts. An 
intriguing question is how Spry2 is induced when cells reach confluence. Possible membrane initiators of the 
intracellular signals engaged by direct cell-to-cell contacts are the N- and VE-cadherins. N- and VE-cadherins 
are components of endothelial adherens junctions [36,37] and interact with cadherins of neighboring cells in a 
homophilic manner [38]. These adhesive complexes strictly depend on extracellular calcium [19,39]. We show 
that Ca
2+
 depletion disrupts cell-cell contacts and rapidly destabilizes Spry2 protein. Conversely, the formation 
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of cell-cell contacts stabilizes Spry2 protein even at a stage, at which an impermeable endothelial barrier is not 
yet completely re-established. Thus, singular cell-cell contacts may already suffice to stabilize Spry2 protein 
levels. Consistent with this notion, previous reports have indicated that cadherin clustering induces signaling, 
and these events may stabilize Spry2 levels, when cells first touch each other before complete confluence is 
reached and junctions are fully stabilized [40,41]. Thus, our findings point to calcium dependent cell-cell 
interactions which are needed for Spry2 expression when cells grow to confluence, with the final evidence of 
proof still to be elucidated in future. The observation that TNF and thrombin increase endothelial permeability 
and at the same time, decrease Spry2 expression further add to the assumption that cell-cell contact upregulate 
Spry2 protein expression. In situations such as inflammation, the endothelial permeability needs to be increased 
to allow transmigration of immune cells to fight pathogens [42]. Since high Spry2 levels correlate with decreased 
endothelial permeability, cells might be forced to restrict Spry2 expression in confluent cells via physiological 
agonists of endothelial permeability such as TNF and thrombin [20-22]. 
At high cell density, cell-cell contact inhibition promotes the switch from an angiogenic and proliferative state to 
a quiescent endothelial cell phenotype. It is assumed that membrane proteins in addition to maintaining cell-cell 
adhesion, also sense cell-cell interactions and transduce this information to intracellular signaling cascades 
[5,43]. In endothelial cells for example, contact inhibition is mediated in part through inhibition of Erk1/2 [8]. 
Spry2 is a well-known feed-back loop inhibitor of RTK signaling and modulates Erk1/2 activity in various 
settings [16]. Therefore, we have hypothesized that Spry2, by inhibiting Erk1/2 activity, promotes cell contact 
inhibition in confluent endothelial cells. Indeed, Spry2 expression correlates with decreased Erk1/2 activity at 
high cell density. Vice versa, ablation of Spry2 in confluent cells increases FGF2-induced but not basal Erk1/2 
signaling. As a result, Spry2
-/-
 cells fail to form a connected monolayer and exhibit a spindle-shaped morphology 
with increased proliferation and monolayer permeability in the presence of FGF2. 
The inability of Spry2
-/-
 cells to form a functional monolayer is likely due to unrestricted FGF2-Erk1/2 signaling 
because Erk1/2 inhibition in Spry2
-/-
 cells restores the wild type-like endothelial cobblestone phenotype. We 
speculate that unrestricted FGF2-Erk1/2 signaling activates Hif-1-induced gene regulation: experimental 
evidence in several studies has demonstrated that FGF2 activates the VEGF/VEGFR system [44,45] in part via 
Hif-1[46-48]. Whereas fine-tuned intracellular VEGF-A/VEGFR-2 signaling supports endothelial survival in 
established mature blood vessels [49], uncontrolled expression of VEGF-A exceeding physiological thresholds 
leads to the formation of unstable and leaky blood vessels [50] or even hemangiomas [51]. Spry2 could 
potentially interfere with this signaling cascade and prevent activation of the VEGF/VEGFR system by FGF in 
quiescent blood vessels.  
Spry2 knockout animals display discrete developmental defects that have been attributed to unrestricted FGF 
signaling [52-55]. Although we observe that Spry2 knockout markedly affected endothelial quiescence and 
integrity in vitro, Spry2 knockout mice seem to exhibit rather mild malformations without an overt vascular 
phenotype. This discrepancy might be due to redundancies amongst the Sprouty isoforms in in vivo models. 
Furthermore, exposition of the knockout animals to stress, such as severe hypoxia or high doses of growth 
factors, might reveal additional Spry2-specific phenotypes.  
FGF signaling has been identified as a strong pro-angiogenic factor in physiological [4] and pathological 
situations [56]. Murakami et al. [57] have demonstrated, however, that it also plays a key role in the maintenance 
of vascular integrity, because disrupted FGF signaling results in severe impairment of the endothelial barrier 
function and eventually to a disintegration of the vasculature. Therefore, we propose that Spry2, by controlling 
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Erk1/2 signaling, switches the response of endothelial cells to FGF2 from proliferation and migration to survival 
and quiescence (Fig. 7).  
In conclusion, the data of the present study show for the first time that high Spry2 expression levels play a 
critical role in endothelial monolayer formation and stabilization by inhibiting FGF2-induced Erk1/2 signaling. 
This negative feedback loop may be important in situations, where endothelial monolayers form, where the 
regulation of basal permeability must be strict, and where vascular integrity and quiescence must be established 
and maintained in vivo. For example, endothelial Spry2 expression might prevent damage to the blood–brain 
barrier and the development of vasogenic brain edema under prolonged hypoxia at high altitude [58] or may 
promote vessel normalization by inhibiting extensive growth-factor signaling in cancer [59]. 
. 
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Figure legends 
 
Fig. 1 Generation of Spry2 knockout MAECs (A) MAECs (♀) were isolated from floxed Spry2 female mice. 
The cells were then exposed to Ade-Cre-GFP Adenovirus or the corresponding Adenovirus without Cre. (B) 
GFP expression 24 hours after transfection with either Ade-Cre-GFP (Spry2
-/-
) or the corresponding control virus 
Ade-CMV-GFP (Spry2
fl/fl
) (scale bar 100 m). (C,D) Efficient knockout of Spry2 was confirmed by qRT-PCR 
analysis (error bars show mean +/- s.e.m.; ***P<0.001; n=3) (B) and immunoblotting analysis (C). -actin was 
used as loading control 
 
Fig. 2 Spry2 knockout results in a loss of contact inhibition and endothelial monolayer integrity (A1,A2) 
Micrographs (scale bar 100 m) display Spry2fl/fl (A1) and Spry2-/- (A2) MAECs (♀) plated at confluence and 
grown for 48 hours in the presence of 1% FCS both with and without FGF2 (25 ng/ml). Magnifications (scale 
bar 50 m) of FGF2-treated Spry2fl/fl and Spry2-/- cells are shown at the bottom of the panel. (B) Modulation in 
monolayer permeability of Spry2
fl/fl 
and Spry2
-/-
 cells in the presence of FGF2. Cells were seeded at confluence 
on a well insert in the presence of 1% FCS with and without FGF2 (25 ng/ml). The permeability of the 
monolayer to 70 kDa FITC-dextran after 10 min was evaluated by measuring fluorescence of the lower well. 
Bars show values as fold change of control +/- s.e.m.; ***P<0.001; n=4. (C) Spry2
-/-
 cells lack contact 
inhibition. Cells were plated at the indicated cell densities and grown for 48 hours in the presence of 1% FCS 
both with and without FGF2 (25 ng/ml). Bars show the FGF2-induced proliferation of Spry2
fl/fl
 and Spry2
-/-
 
MAECs (♀) normalized to the unstimulated cell at the indicated plating densities +/- s.e.m.; ***P<0.001 vs. 
3,000 cells/cm
2
 + FGF2; ##P<0.01; ###P<0.001 Spry2
fl/fl
 vs. Spry2
-/-
; ns=non-significant; n=3 
 
Fig. 3 High cell density induces Spry2 (A) Representative micrographs of MAECs (♂) plated at different cell 
numbers (scale bar 100 m). (B) MAECs (♂) were subjected to immunoblotting after 24 hours of serum 
starvation. (C) mRNA expression of sparse (3,000 cells/cm
2
) and confluent cells (50,000 cells/cm
2
) was analyzed 
by qRT-PCR and compared to the corresponding protein expression (Spry2/-Actin) of sparse and confluent 
cells (MAECs ♂). The present graphs summarize at least three independent experiments. The values shown are 
means +/- s.e.m.; **P<0.01; ***P<0.001 vs. 3,000 cells/cm
2
. (D,E) Cells (MAECs ♂) growing to confluence 
increase Spry2. (D) Micrographs (scale bar 100 m) of MAECs plated at sparse condition (3,000 cells/cm2) and 
grown for the indicated time. (E) Cell (MAECs ♂) samples were collected at the indicated times and Spry2 and 
-actin levels were analyzed by immunoblotting 
 
Fig. 4 Hypoxia increases Spry2 protein expression (A) Cells (MAECs ♂) growing to confluence become 
hypoxic. Cell samples were collected at the indicated times and analyzed for Hif-1 and -actin protein 
expression. (B) Real-time measurement of the oxygen consumption of MAECs (♂) growing to confluence 
(initially plated at sparse density; 3,000 cells/cm
2
) (C) Cells (MAECs ♂) were grown in 10% FCS for 24 hours 
and then either collected or starved for 24 hours, and then Spry2 levels were determined by immunoblotting. 
Three independent experiments, normalized to -actin expression, are summarized in a graph that shows 
densitometric quantification of the immunoblotting signals (**P<0.01). (D) In parallel experiments, real time 
oxygen consumption of growing and quiescent cells (MAECs (♂) plated at confluence; 50,000 cells/cm2). After 
24 hours, either serum free or media with 10 % FCS was added for additional 24 hours to the cells (indicated 
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with a dashed line). (D) MAECs (♂) were grown for 24 hours and then starved and grown under either hypoxic 
(1% O2) or normoxic (21 % O2) conditions before lysis and immunoblotting for Spry2, Hif-1 and -actin. 
Three independent experiments, normalized to -actin expression, are summarized in a graph that shows 
densitometric quantification of the bands (**P<0.01). (H) mRNA was collected from MAECs (♂) grown for 24 
hours and then starved and grown under either hypoxic (1% O2) or normoxic (21 % O2) conditions and analyzed 
for Spry2 expression by qRT-PCR. Values were normalized to GAPDH; n=4  
 
Fig. 5 Disruption of cell-cell contacts decrease Spry2 protein levels (A, panels 1-3) Micrographs (scale bar 100 
m) of MAECs (♂) plated at confluence and treated with PBS (the control) or EGTA for the indicated time. (A, 
panel 4) After 3 hours, EGTA was replaced by fresh growth media, and cells were grown for an additional 24 
hours. (B) Spry2 expression after EGTA treatment. MAECs (♂) were collected after the indicated incubation 
time with PBS (control) or EGTA or 24 hours after replacement of EGTA with fresh media (3.0 + 24). (C) Cells 
were plated at confluence, and total resistance was measured in real time by ECIS. When cells reached a steady 
plateau in resistance (baseline), either EGTA or PBS (control) was added to the cells. After 8 hours, new media 
was added to all cells and the time point was set to zero. (D) MAECs (♂) were treated with either EGTA or 
BAPTA-AM for 3 hours, and Spry2 and -actin expression were analyzed by immunoblotting. (E) In parallel 
experiments, total RNA was isolated from MAECs (♂) that had been treated with EGTA, BAPTA-AM, or PBS. 
Spry2 mRNA levels were determined by using qRT-PCR and normalized to GAPDH. The values shown are 
means +/- s.e.m.; n=3. (F) MAECs (♂) were plated at confluence and then treated with either TNF (50 ng/ml), 
thrombin (10 u/ml) or PBS for 3 hours. Cells were then lysed and analyzed for Spry2 and -actin expression by 
immunoblotting. (G) In parallel experiments, total resistance was measured in real time by ECIS. When the cells 
reached the plateau, either TNF (50 ng/ml), thrombin (10 u/ml) or PBS was added for the indicated time 
  
Fig. 6 Inhibition of Erk1/2 signaling restores wild type morphology of the Spry2
-/-
monolayer (A) High cell 
density-induced Spry2 correlates with decreased Erk1/2 phosphorylation. Sparse (3,000 cells/cm
2
) or confluent 
MAECs (♂) (50,000 cells/cm2) were starved and then treated with FGF2 (25 ng/ml) or PBS for 24 hours before 
lysis and immunoblotting. Relative phosphorylation levels of Erk1/2 were quantified by densitometry. Bars show 
values as fold change of unstimulated sparse cells +/-s.e.m.; **P<0.01; ***P<0.001; n=3. (B) Micrographs 
displaying Spry2
fl/fl
 and Spry2
-/-
 MAECs (♀) plated at confluence in the absence or presence of FGF2 (25 ng/ml) 
and then grown for 48 hours. Where indicated, cells were incubated with U0126 (5 M) 1 hour prior the addition 
of FGF2 (scale bar 100 m). (C1) MAECs (♀) were plated at confluence in the presence or absence of FGF2 
both with and without pre-incubation with U0126 (5 M). Cells were collected 4 hours after seeding and 
phosphorylated Erk1/2 (p-Erk1/2), total Erk1/2 (t-Erk1/2), Spry2 and -actin were analyzed by immunoblotting. 
(C2) Relative phosphorylation levels of Erk1/2 were quantified by densitometry. Bars show values as fold 
change of FGF2-stimulated Spry2
fl/fl 
cells +/- s.e.m.; **P<0.01; n=3 
 
Fig. 7 A working model for the regulation of Spry2-dependent endothelial quiescence and integrity (A) In wild 
type endothelial cells (Spry2
fl/fl
), Spry2 is upregulated by increasing cell density via transient hypoxia in 
subconfluent cells and cell-cell contacts in confluent cells via a yet unknown mechanism. Spry2 expression 
allows the endothelial monolayer to retain its integrity and cell quiescence, upon FGF stimulation. (B) In the 
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absence of Spry2 (Spry2
-/-
), FGF signaling extensively activates Erk1/2. Erk1/2 elicits an endothelial phenotype 
change from cobble-stone to spindle-shape endothelial cells, induces proliferation, and increases permeability 
 
Supplementary figure 1 Male and female MAECs show similar FGF2-Erk1/2 signaling and density dependent 
Spry2 expression (A) Confluent female (♀) and male (♂) MAECs were starved and stimulated with FGF2 for 
the indicated time. The cells were then lysed and analyzed for ERK1/2 phosphorylation and total Erk1/2 
expression. Relative phosphorylation levels of Erk1/2 were quantified by densitometry. Bars show values as fold 
change of unstimulated cells +/- s.e.m. n=3. (B) Basal Spry2 expression and Erk1/2 activity in sparse and 
confluent female and male MAECs. Cells were plated at sparse (3,000 cells/cm
2
) or confluent conditions (50,000 
cells/cm
2
), starved, lysed and analyzed by immunoblotting  
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Summary of all changes in the figures of the revised manuscript: 
 
 
Figure 5  
 
Panel F now displays Spry2 protein expression 3 hours after addition of either TNF thrombin or PBS (control) 
to confluent cells. 
 
Panel G now displays the normalized resistance of confluent cells treated with either TNF, thrombin or PBS 
(control) for the indicated time. 
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